Generic name:glycopyrrolate (inhalation route) [ glye-koe-PIR-oh-late ]
Drug class:Anticholinergic bronchodilators
Medically reviewed by Drugs.com. Last updated on May 26, 2022.
Commonly used brand name(s)
In the U.S.
- Lonhala Magnair
- Seebri Neohaler
Available Dosage Forms:
- Solution
Therapeutic Class: Bronchodilator
Pharmacologic Class: Antimuscarinic
Uses for Lonhala Magnair
Inhaled glycopyrrolate is used to treat air flow blockage and prevent worsening of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. COPD is a long-term lung disease that causes bronchospasm (difficulty with breathing).
This medicine is available only with your doctor's prescription.
Before using Lonhala Magnair
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Use of inhaled glycopyrrolate is not recommended in children. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of inhaled glycopyrrolate in the elderly.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, i...
